Developing new lenses for cataract surgery that resist cell growth
Improving Outcomes in Cataract Surgery: Intraocular Lenses (IOLs) Resistant to Cell Growth
['FUNDING_R21'] · TEXAS ENGINEERING EXPERIMENT STATION · NIH-10783729
This study is testing a new type of silicone lens for cataract surgery that aims to prevent common complications, like cloudy vision after surgery, so patients can have a better experience and possibly avoid extra surgeries.
Quick facts
| Phase | ['FUNDING_R21'] |
|---|---|
| Study type | Nih_funding |
| Sex | All |
| Sponsor | TEXAS ENGINEERING EXPERIMENT STATION (nih funded) |
| Locations | 1 site (COLLEGE STATION, UNITED STATES) |
| Trial ID | NIH-10783729 on ClinicalTrials.gov |
What this research studies
This research focuses on improving cataract surgery outcomes by creating intraocular lenses (IOLs) that resist the growth of lens epithelial cells, which can lead to complications after surgery. The study aims to develop a new type of silicone lens that minimizes the risk of posterior capsule opacification (PCO), a common issue affecting around 40% of patients. By integrating innovative surface-modifying additives into the lens design, the researchers hope to enhance the performance of IOLs while maintaining their mechanical properties. This could potentially reduce the need for additional surgeries to correct complications, improving overall patient experiences.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals scheduled for cataract surgery, particularly those from underrepresented or medically underserved populations.
Not a fit: Patients who have already undergone cataract surgery and do not require lens replacement may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to safer cataract surgeries with fewer complications and reduced need for follow-up procedures.
How similar studies have performed: Previous research has shown promise in developing innovative IOL materials, suggesting that this approach could lead to significant advancements in cataract surgery outcomes.
Where this research is happening
COLLEGE STATION, UNITED STATES
- TEXAS ENGINEERING EXPERIMENT STATION — COLLEGE STATION, UNITED STATES (ACTIVE)
Researchers
- Principal investigator: GRUNLAN, MELISSA — TEXAS ENGINEERING EXPERIMENT STATION
- Study coordinator: GRUNLAN, MELISSA
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.